Improving Care and Outcomes in Type 2 Diabetes: A Nurse Practitioner-Led Charge for Overcoming Insulin Inertia
The I’s Have It
Release Date: June 11, 2018
Expiration Date: June 30, 2019 (subject to change)
- CE for this activity will not be available after this date.
For approximately 30% of the 21 million people in the United States with type 2 diabetes mellitus, insulin therapy plays a large role as part of their treatment plan. However, despite the availability of a number of insulin products, optimal glycemic control is often not achieved. Although treatment intensification has been shown to improve glycemic control and reduce microvascular risk, clinical inertia related to the initiation of basal insulin frequently occurs in diabetes care. Both clinician- and patient-related barriers contribute to clinical inertia and resistance to initiating basal insulin therapy. Therefore, nurse practitioners practicing in the primary care setting need to recognize the effects of inefficient glycemic control, identify the benefits and limitations of initiating basal insulin therapy, particularity newer basal insulins that may help mitigate negative effects associated with insulin, and use strategies to ensure timely treatment intensification.
CE Credit Instructions
- Read this activity description, including objectives and disclosures.
- Complete the educational content completely:
- Video Presentations: Watch all video presentations completely.
- Review all additional materials provided (handouts, posttest reviews, any other downloadable resources).
- After completing all content, go to Steps to Receive Credit to complete the posttest and evaluation to receive full AANP CE/Rx credit. If other types of credit are offered, these options will be available after completing the activity evaluation.
- Integrate strategies to overcome patient barriers to insulin initiation
- Improve appropriate integration of basal insulin therapy
- Examine clinical data surrounding long-acting basal insulins, including differences in PK/PD properties
Shannon Idzik, DNP, CRNP, FAANP, FAAN
Frances M. Sahebzamani, Ph.D., ARNP, FAANP
Angela Thompson, DNP, FNP-C, BC-ADM, CDE, FAANP
Amy Burdette, PhD
Samantha Gordon, CME Specialist
Kathryn Schaefer, MSN, RN
Michele L. McKay, MSN, APRN, FNP-C
This activity was planned in accordance with AANP Accreditation Standards and Policies. It is provided in collaboration with Med-IQ and supported by an educational grant from Sanofi US. The activity faculty, planners, and peer reviewers have no relevant affiliations to disclose.
Med-IQ and the AANP require any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ and the AANP have policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ and the AANP also require faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
The content of this activity has been peer reviewed and has been approved for compliance.
This educational activity may contain opinions of the speakers from their personal experience. The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
For questions about this online CE activity, or more information concerning the AANP CE Center, contact the AANP CE Center Manager at CECenter@aanp.org.
|0.5 Contact Hour(s) of CE,
All of which may be applied towards Pharmacology
Additional CE activities of interest
Starting & Adjusting Insulin in Type 2 Diabetes in Primary Care
What’s New in Oral Medications for T2DM?
Untying the Shoe, Management of the Diabetic Foot
Introductory Certificate of Obesity Management in Primary Care (Modules 1-7)
The Complexities of Sodium Imbalances
Useful Tools for Promoting Behavior Change and Self-Management in Diabetes and Prediabetes